Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate
US11530184B2 · kind B2 · utility
1Cited by
49References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 28, 2021 |
| Grant date | Dec 20, 2022 |
| Priority date | — |
| Expiry date | Jun 28, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides polymorphs of a compound of Formula (X):The invention also provided pharmaceutical compositions containing polymorphs of the compound and methods treating conditions in a subject by providing polymorphs of the compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.